Tempus has announced that the US Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG analysis platform
However, individual tolerance varies considerably, and some people experience adverse effects at lower doses
That is a 67% waste rate
A 2025 study evaluating the short-term management of obesity found that subcutaneous Tirzepatide was cost-effective compared to both subcutaneous and oral semaglutide, with an incremental cost-effectiveness ratio (ICER) of $34,212 per quality-adjusted life-year (QALY) gained versus oral semaglutide, well below the common willingness-to-pay threshold of $150,000/QALY
However, due to their mechanism of action, primarily appetite suppression, GLP-1 analogs have been associated with various adverse effects
However, some employer- or insurer-specific plans have chosen to continue covering it so coverage is now highly individualized and may vary based on your specific benefits package